Article Text
Therapeutics
Randomised controlled trial
Hydroxycarbamide for very young children with sickle cell anaemia: no effect on the primary outcomes of spleen or kidney function, but evidence for decreased pain and dactylitis, with minimal toxicity
Statistics from Altmetric.com
Footnotes
-
Competing interests None.